KYNVIT
LIVE

Serial Number

98077166

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

KYNVIT Trademark

Serial Number: 98077166

KYNVIT is a trademark filed by NOVARTIS AG on July 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 10, 2023

Registration Date

Not Registered

Published for Opposition

April 30, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above excluding pharmaceutical preparations for the treatment of adenosine deaminase deficiency called SCID-ADA and excluding pharmaceutical preparations for the prevention and treatment of cancer and tumors

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 19, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 19, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 19, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 19, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 23, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 23, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 23, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2024 EXRA
SOU EXTENSION 1 GRANTED
Dec 20, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 20, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 20, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 25, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2024 CNSA
ASSIGNED TO EXAMINER
Mar 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2023 NWOS
NEW APPLICATION ENTERED
Jul 13, 2023 NWAP